ArticleExpert systems with applications2023
EffViT-COVID: A dual-path network for COVID-19 percentage estimation.
Article in Expert systems with applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The first case of novel Coronavirus (COVID-19) was reported in December 2019 in Wuhan City, China and led to an international outbreak. This virus causes serious respiratory illness and affects several other organs of the body differently for different patient. Worldwide, several waves of this infection have been reported, and researchers/doctors are working hard to develop novel solutions for the COVID diagnosis. Imaging and vision-based techniques are widely explored for the prediction of COVID-19; however, COVID infection percentage estimation is under explored. In this work, we propose a novel framework for the estimation of COVID-19 infection percentage based on deep learning techniques. The proposed network utilizes the features from vision transformers and CNN (Convolutional Neural Networks), specifically EfficientNet-B7. The features of both are fused together for preparing an information-rich feature vector that contributes to a more precise estimation of infection percentage. We evaluate our model on the Per-COVID-19 dataset (Bougourzi et al., 2021b) which comprises labeled CT data of COVID-19 patients. For the evaluation of the model on this dataset, we employ the most widely-used slice-level metrics, i.e., Pearson correlation coefficient (PC), Mean absolute error (MAE), and Root mean square error (RMSE). The network outperforms the other state-of-the-art methods and achieves
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.